NCT05339919 is a clinical trial of gait speed; ct scan;grip strength and chair stand test in Liver Cancer, sponsored by First Affiliated Hospital of Wenzhou Medical University.

Who is sponsoring NCT05339919?

NCT05339919 is sponsored by First Affiliated Hospital of Wenzhou Medical University.

What drugs are being tested in NCT05339919?

Interventions in NCT05339919: gait speed; ct scan;grip strength and chair stand test.

What condition does NCT05339919 study?

NCT05339919 studies Liver Cancer, Sarcopenia.

Is NCT05339919 still recruiting?

NCT05339919 is currently status unknown. Last updated 15 June 2022.

Last reviewed 2022-06-15 · How we verify

NCT05339919

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Relationship Between Liver Cancer and Sarcopenia

Status unknown Last updated 15 June 2022

What this trial tests

trial testing gait speed; ct scan;grip strength and chair stand test in Liver Cancer in 1,200 participants. Status unknown.

Timeline

1 May 2020

Primary endpoint
11 August 2021

28 August 2025

Quick facts

Lead sponsor	First Affiliated Hospital of Wenzhou Medical University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,200
Start date	1 May 2020
Primary completion	11 August 2021
Estimated completion	28 August 2025
Sites	1 location across China

Drugs / interventions tested

gait speed; ct scan;grip strength and chair stand test

Conditions studied

Liver Cancer — all drugs for Liver Cancer →
Sarcopenia — all drugs for Sarcopenia →

Sponsor

First Affiliated Hospital of Wenzhou Medical University

Who can join

18 and older, any sex, with Liver Cancer or Sarcopenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

By tracking the short-term and long-term results of patients after hepatectomy, the difference of short-term results between patients with sarcopenia and patients without sarcopenia was analyzed, and the correlation between sarcopenia and short-term and long-term results of patients after hepatectomy was explored, so as to improve people's awareness of sarcopenia and pay attention to its prevention and treatment.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of Sarcopenia on Survival and Health-Related Quality of Life in Patients with Hepatocellular Carcinoma after Hepatectomy.
Hu J, Yang J, Yu H, Bo Z, et al · · 2022 · cited 8× · PMID 36551629 · DOI 10.3390/cancers14246144

Verify or expand the search:

Other recruiting trials for Liver Cancer

Currently open trials in the same condition.

NCT07295275 — Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection · recruiting
NCT07410494 — Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors · Phase 1, PHASE2 · recruiting
NCT07295340 — Diagnostic Accuracy of Folate-Targeted NIR-II Carbon Dots for Ex Vivo HCC Detection · recruiting
NCT07504367 — Large Language Models Assist in Tumor MDT · NA · recruiting
NCT07447050 — Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial · Phase 2 · recruiting

Other First Affiliated Hospital of Wenzhou Medical University trials

Trials by the same sponsor.

NCT07394205 — Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Can · EARLY_PHASE1 · not yet recruiting
NCT07179120 — Can Fat-Burning Shots Boost Fertility? Comparing Weight-Loss Injections vs. Healthy Habits for Obese Men With Low Sperm · Phase 2 · not yet recruiting
NCT07495735 — Intelligence System for Predicting Atezolizumab-Bevacizumab Response and Clinical Outcomes in Unresectable Hepatocellula · not yet recruiting
NCT07381634 — The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities · Phase 2 · not yet recruiting
NCT07284524 — Intelligent Precision Knee Preservation System for Knee Osteoarthritis · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05339919 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by First Affiliated Hospital of Wenzhou Medical University
Last refreshed: 15 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05339919.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing